Dhanya T M

Dr. Dhanya T M

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 January 2025 in Dalton Transactions
Verified
Journal Article
Closed access
PDF file
DMDhanya T M
Dhanya T M
MKM. R. Prathapachandra Kurup
M. R. Prathapachandra Kurup
Rajimon K JRajimon K J
Rajimon K J
GKG. Anjali Krishna
G. Anjali Krishna
JVJibin K. Varughese
Jibin K. Varughese
PMP. V. Mohanan
P. V. Mohanan
The rise of various diseases demands the development of new agents with antioxidant, antimicrobial, anti-inflammatory, enzyme-inhibiting, and cytotoxic properties. In this study, heterocyclic Schiff base complexes of Cu(II) featuring a benzo[b]thiophene moiety were synthesized and their biological activities evaluated. The complexes were characterized using FT-IR, UV-Vis, and EPR spectroscopy, TG–DTG analysis, magnetic moment measurements, molar conductivity measurements, and elemental analyses. Density functional theory (DFT) calculations were used to optimize the theoretical molecular orbital energies of the copper complexes. The complexes exhibited square pyramidal and square planar geometries. Biological assays demonstrated that these complexes generally outperformed the Schiff base ligands for various activities. The antioxidant capacity, measured via the DPPH assay in methanol, was comparable to those of the BHT and ascorbic acid standards, with 4BNPC showing the lowest IC50 value, which was attributed to the free OH group rather than coordination to the metal center. The anti-bacterial activity was assessed using the agar disc diffusion method against E. coli, P. aeruginosa, B. subtilis, and S. aureus, with BAC showing the largest inhibition zone compared to the others and ciprofloxacin as the reference. The anti-inflammatory activity, evaluated by the HRBC membrane stabilization method, showed that the 4BNPC Cu(II) complex had moderate activity similar to that of diclofenac. Enzyme inhibition studies against α-amylase revealed that the BAC complexes had the highest inhibition values, surpassing those of the Schiff base ligands. Cytotoxicity was assessed using Trypan blue exclusion for DLA and HepG2 cancer cell lines, and the MTT assay for H9c2 human cells. BMPC demonstrated superior cytotoxicity at both high and low concentrations against the normal H9c2 cell line. Among the tested compounds, BNPC showed moderate inhibition against HepG2 cells, while BMPC exhibited the greatest cytotoxicity at higher concentrations, particularly reaching nearly 100% cell death at 200 μg mL−1 in DLA cell lines. This suggests that BMPC is a promising candidate for further pharmacological research, particularly against DLA cells.

21 November 2024 in Discover Chemistry
Verified
Journal Article
Open access
PDF file
DMDhanya T M
Dhanya T M
Rajimon K JRajimon K J
Rajimon K J
NMNANDU K MOHANAN
NANDU K MOHANAN
AAAparna Anilkumar
Aparna Anilkumar
SPSaumya S Pillai
Saumya S Pillai
PMP V Mohanan
P V Mohanan
Benzothiophene, a sulfur-containing heterocycle, plays a crucial role in pharmaceutical and biological research due to its low toxicity, high solubility, and bioavailability. This aromatic structure, comprising a six-membered ring fused with a thiophene moiety, serves as a key scaffold for synthesizing biologically significant compounds. Benzothiophene derivatives exhibit diverse biological and pharmacological activities, including antimicrobial, anticancer, anti-inflammatory, antioxidant, antimalarial, antidiabetic, and enzyme-inhibiting properties. This study utilizes the synthesis of Schiff base ligands with the benzothiophene moiety to build coordination complexes with metals. The electron-rich sulfur and aromaticity of the benzo[b]thiophene core are well-known for their ability to stabilise the metal centres and have an impact on the coordination compounds' overall shape and reactivity. This review focuses on the advancements in the biological activities of benzothiophene compounds, emphasizing their potential as Schiff base metal complexes with enzyme-inhibiting capabilities. The discussion aims to provide new insights into the development of safer and more effective benzothiophene-based medicinal drugs, analytical agents, and pathological probes.

27 January 2025 in New Journal of Chemistry
Verified
Journal Article
Closed access
PDF file
DMDhanya T M
Dhanya T M
Rajimon K JRajimon K J
Rajimon K J
JVJibin K. Varughese
Jibin K. Varughese
RGRaghu K G
Raghu K G
GKG. Anjali Krishna
G. Anjali Krishna
PMP. V. Mohanan
P. V. Mohanan
New effective antioxidant, antimicrobial, anti-inflammatory, enzyme-inhibiting, and cytotoxic agents with novel modes of action are urgently needed due to the continued emergence of various diseases. Four novel Schiff base ligands containing a benzo[b]thiophene moiety were synthesized, leading to the development of a versatile class of Ni(II) and Mn(II) complexes, which were screened for their biological applications. The Schiff base ligands were characterized quantitatively using standard spectroscopic techniques such as elemental analysis, UV-vis spectroscopy, FT-IR spectroscopy, LC-MS, 1H NMR spectroscopy and 13C NMR spectroscopy, while the metal complexes were characterized using UV-vis spectroscopy, FT-IR spectroscopy, CHNS analysis, ICP-MS, thermal analysis (TG and DTG), molar conductance and magnetic susceptibility measurements. The coordination structure of the complexes was found to be octahedral geometry, with Ni(II) and Mn(II) metal ions coordinated to a nitrogen atom of azomethine group, a benzo[b]thiophene ring, an oxygen atom of the phenolic group and an acetate derivative. Among the synthesized compounds, the biological properties of the complexes were found to be more potent than those of Schiff base ligands. Their antioxidant, antibacterial, anti-inflammatory, enzyme inhibitory, and cytotoxic activities were assessed. The antioxidant activity of the developed compounds was tested using the 1,1-diphenyl-2-picrylhydrazyl (DPPH) assay in methanol and buffered methanol solutions. All the Schiff base ligands and their Ni(II)/Mn(II) complexes exhibited antioxidant activities comparable to the standards (BHT and ascorbic acid). The in vitro antibacterial activity of the synthesized compounds was evaluated against Escherichia coli (E. coli), Pseudomonas aeruginosa (P. aeruginosa), Bacillus subtilis (B. subtilis), and Staphylococcus aureus (S. aureus) and their antifungal activity using fungal strains, such as Aspergillus niger (A. niger), and Candida albicans (C. albicans). These activities were observed using the agar disc diffusion method, with ciprofloxacin and nystatin as the reference drugs. The HRBC membrane stabilization method was applied to measure anti-inflammatory activity, and one of the Mn(II) compounds showed moderate anti-inflammatory activity, which was compared with the standard drug diclofenac. Enzyme inhibition studies were conducted on benzo[b]thiophene-derived Schiff base ligands and their complexes with the enzyme α-amylase, using acarbose as the standard. The Ni(II) complexes exhibited the best enzyme inhibition value (Ki). To assess the cytotoxic behavior of the synthesized compounds and determine cell viability, two methods were used: the trypan blue exclusion method for cancer cell lines, such as DLA cells and HepG2 cells, and the MTT assay for human cells, such as H9c2 cells. Encouragingly, most of the compounds were generally non-toxic to the human cells (H9c2).

4 August 2025 in Inorganics
Verified
Journal Article
Open access
PDF file
NMNANDU K MOHANAN
NANDU K MOHANAN
NMNandana S Mohanan
Nandana S Mohanan
SSSurya Mol Sukumaran
Surya Mol Sukumaran
DMDhanya T M
Dhanya T M
Sneha S PillaiSneha S Pillai
Sneha S Pillai
SPSaumya S Pillai
Saumya S Pillai
Growing interest in the future applications of nanotechnology in medicine has led to groundbreaking developments in nanosensors. Nanosensors are excellent platforms that provide reliable solutions for continuous monitoring and real-time detection of clinical targets. Nanosensors have attracted great attention due to their remarkable sensitivity, portability, selectivity, and automated data acquisition. The exceptional nanoscale properties of nanomaterials used in the nanosensors boost their sensing potential even at minimal concentrations of analytes present in a clinical sample. Along with applications in diverse sectors, the beneficial aspects of nanosensors have been exploited in healthcare systems to utilize their applications in diagnosing, treating, and preventing diseases. Hence, in this review, we have presented an overview of the disease-prognostic applications of nanosensors in chronic diseases through a detailed literature analysis. We focused on the advances in various nanosensors in the field of major diseases such as cancer, cardiovascular diseases, diabetes mellitus, and neurodegenerative diseases along with other prevalent diseases. This review demonstrates various categories of nanosensors with different nanoparticle compositions and detection methods suitable for specific diagnostic applications in clinical settings. The chemical properties of different nanoparticles provide unique characteristics to each nanosensors for their specific applications. This will aid the detection of potential biomarkers or pathological conditions that correlate with the early detection of various diseases. The potential challenges and possible recommendations of the applications of nanosensors for disease diagnosis are also discussed. The consolidated information present in the review will help to better understand the disease-prognostic potentials of nanosensors, which can be utilized to explore new avenues in improved therapeutic interventions and treatment modalities.